Cambium Bio Ltd (cmb) Logo

Cambium Bio Ltd (CMB)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
Stock Scores NEW
News
Announcements

CMB ASX Chart

Snapshot

Cambium Bio Limited (CMB) is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue repair applications.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +0.71%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,815 of 2,354
Sector Rank 175 of 244

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies 1AD / IVXDB / NOX
EPS -$0.172
DPS $0.00
Book Value Per Share $0.081

Broker Consensus

CMB is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Bella Vista NSW 2153
Website www.cambium.bio
Registry MUFG Corporate Markets (AU) Limited
Auditor Stantons International Audit and Consulting Pty Ltd
Date Listed 19 Sep 2013

Upcoming Calendar (Forecasted)

Date Event
19/02/2027 Report (Interim)
27/08/2027 Report (Prelim)
27/08/2027 Report (Annual)

Former Company Names

  • Regeneus Ltd (RGS), 10/04/2024

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CMB directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
17/03/26 Yu-Hung Tseng Issued 4,363,637 $0.55 $2,400,000 Placement
16/10/25 Terence Walts Issued 54,950 $0.464 $25,480 Placement
16/10/25 Terence Walts Issued 120,000 $0.46 $55,200 Director remuneration
16/10/25 Edmund Waller Issued 60,000 $0.464 $27,822 Placement
16/10/25 Edmund Waller Issued 120,000 $0.46 $55,200 Director remuneration
12/03/25 Terence Walts Issued 120,000 $0.35 $42,000 Director remuneration
12/03/25 Terence Walts Issued 54,950 $0.464 $25,480 Placement
12/03/25 Terence Walts Issued 50,000 $0.464 $23,185 Placement
12/03/25 Edmund Waller Issued 50,000 $0.464 $23,185 Placement
12/03/25 Yu-Hung Tseng Issued 3,773,993 $0.464 $1,750,000 Placement
12/03/25 Yu-Hung Tseng Issued 215,657 $2.76 $595,479 Placement
12/03/25 Chandra Bala Issued 50,000 $0.464 $23,185 Placement
12/03/25 Chandra Bala Issued 120,000 $0.35 $42,000 Issue of options
28/06/24 Yu-Hung Tseng Issued 175,469,372 $0.006 $1,052,816 As advised by the company
28/06/24 Yu-Hung Tseng Issued 17,546,938 $0.006 $105,282 As advised by the company

Director Interests

The current holdings of CMB directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Denese Marks 30/06/2026 N/A N/A N/A N/A
Li Chiu 30/06/2026 1,118,275 N/A N/A N/A
Chandra Bala 30/06/2026 50,000 N/A 120,000 N/A
Yu-Hung Tseng 30/06/2026 11,280,229 N/A N/A N/A
Edmund Waller 30/06/2026 338,932 N/A 120,000 N/A
Terence Walts 30/06/2026 370,957 N/A 120,000 N/A
ChiTai Chang 10/10/2024 N/A 2,384,359 N/A N/A
Olga Smejkalova N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 20, 2026.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Zheng Yang Biomedical Technology Limited 10,826,136 36.78%
J P Morgan Nominees Australia Pty Limited 5,609,060 19.06%
Cyntec Co Ltd 2,384,359 8.10%
Chen Tsung Chi 1,222,665 4.15%
Treasury Century Group Limited 999,002 3.39%
Li Chien Ken Chiu 800,357 2.72%
Apex Metro Investments Limited 691,580 2.35%
Chen Yu Chen 539,142 1.83%
Yu Hung Sebastian Tseng 454,093 1.54%
Citicorp Nominees Pty Limited 438,330 1.49%
Edmund Kemp Waller 338,932 1.15%
Showcity Pty Ltd 336,947 1.14%
Mu Ni Chiu 317,915 1.08%
Terence Allen Walts 277,855 0.94%
Sancoast Pty Ltd 250,000 0.85%
Mr Christopher James Brack 250,000 0.85%
John Donald Roback 192,100 0.65%
Jennifer Heather Copland 185,472 0.63%
Whale Watch Holdings Limited 183,699 0.62%
Jacques Galipeau 183,636 0.62%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 948 183 38 48 25 1,242

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Chen Tsung Chi 20/08/2026 1,222,665 4.20
J P Morgan Nominees Australia Limited 20/08/2026 5,509,060 18.70
Cyntec Co Ltd 20/08/2026 2,384,359 8.10
Zheng Yang Biomedical Technology Co Ltd 20/08/2026 10,826,136 36.80

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
24-07-26 Wu Chun Yi 2,100,000 14.65 18.51

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
17-03-26 Zheng Yang Biomedical Technology Co Ltd 281,413,941 24.53 41.3
17-03-26 Chen Tsung Chi 1,222,665 5.35 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.21 30 June
2024 $0.005 28 June
2023 $0.007 30 June
2022 $0.061 30 June
2021 $0.074 30 June
2020 $0.07 30 June
2019 $0.085 28 June
2018 $0.12 29 June
2017 $0.115 30 June
2016 $0.125 30 June
2015 $0.15 30 June
2014 $0.39 30 June
CMB Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.